1. Home
  2. MRBK vs VYGR Comparison

MRBK vs VYGR Comparison

Compare MRBK & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meridian Corporation

MRBK

Meridian Corporation

HOLD

Current Price

$18.95

Market Cap

222.3M

Sector

Finance

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.87

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRBK
VYGR
Founded
2004
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
222.3M
194.0M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
MRBK
VYGR
Price
$18.95
$3.87
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$20.00
$21.00
AVG Volume (30 Days)
72.6K
873.3K
Earning Date
04-24-2026
03-09-2026
Dividend Yield
2.97%
N/A
EPS Growth
30.34
N/A
EPS
1.89
N/A
Revenue
$6,316,000.00
$10,135,000.00
Revenue This Year
$25.40
$33.19
Revenue Next Year
$8.15
$14.68
P/E Ratio
$9.98
N/A
Revenue Growth
10.13
N/A
52 Week Low
$11.17
$2.65
52 Week High
$21.03
$5.55

Technical Indicators

Market Signals
Indicator
MRBK
VYGR
Relative Strength Index (RSI) 49.83 45.91
Support Level $18.10 $3.72
Resistance Level $19.53 $4.43
Average True Range (ATR) 0.64 0.27
MACD 0.02 -0.04
Stochastic Oscillator 52.48 15.27

Price Performance

Historical Comparison
MRBK
VYGR

About MRBK Meridian Corporation

Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: